Regenosine’s Post

Regenosine is excited to announce that our Founder and CEO Sid Angle will present our groundbreaking research at the prestigious OARSI - Osteoarthritis Research Society International's 2024 World Congress on Osteoarthritis in Vienna, Austria this week. 📊 Abstract #377: Intra-articular Injections Of Liposomal Adenosine For Slowing Progression Of Osteoarthritis In A Preclinical Canine Model This study validates the potential of intra-articular liposomal adenosine injections and their capacity to decelerate the progression of osteoarthritis while enhancing pain relief and joint function. If you're attending, let's connect and exchange insights. For those who cannot join, stay tuned for updates on our presentation and the impact this research carries for both veterinary and human medicine. #OARSI2024 #Regenosine #Vetosine #Pain #DiseaseModification #DiseaseModifyingTherapy #Osteoarthritis #OsteoarthritisResearch #VeterinaryMedicine

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics